FKACX
Price
$36.44
Change
-$0.06 (-0.16%)
Updated
Sep 20 closing price
RGAHX
Price
$75.98
Change
-$0.14 (-0.18%)
Updated
Sep 20 closing price
Ad is loading...

FKACX vs RGAHX

Header iconFKACX vs RGAHX Comparison
Open Charts FKACX vs RGAHXBanner chart's image
Franklin Growth Opportunities C
Price$36.44
Change-$0.06 (-0.16%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer R5E
Price$75.98
Change-$0.14 (-0.18%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
FKACX vs RGAHX Comparison Chart
Loading...
VS
FKACX vs. RGAHX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FKACX is a StrongBuy and RGAHX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RGAHX has more cash in the bank: 290B vs. FKACX (4.7B). RGAHX pays higher dividends than FKACX: RGAHX (0.64) vs FKACX (0.00). FKACX was incepted earlier than RGAHX: FKACX (25 years) vs RGAHX (9 years). RGAHX is a more actively managed with annual turnover of: 31.00 vs. FKACX (16.52). RGAHX has a lower initial minimum investment than FKACX: RGAHX (250) vs FKACX (1000). RGAHX annual gain was more profitable for investors over the last year : 30.34 vs. FKACX (17.51). RGAHX return over 5 years is better than : 54.03 vs. FKACX (11.81).
FKACXRGAHXFKACX / RGAHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence25 years9 years-
Gain YTD22.11821.860101%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets4.7B290B2%
Annual Yield % from dividends0.000.64-
Returns for 1 year17.5130.3458%
Returns for 3 years-25.070.79-3,188%
Returns for 5 years11.8154.0322%
Returns for 10 years33.82N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PPTA8.760.16
+1.86%
Perpetua Resources Corp
YHGJ1.010.01
+1.01%
Yunhong Green CTI Ltd
ARQT10.150.01
+0.10%
Arcutis Biotherapeutics
MATX134.72-2.46
-1.79%
Matsons
CSGP77.36-1.93
-2.43%
CoStar Group